Saudi Arabia Digital Therapeutics Market Research Report: Forecast (2026-2032)

Saudi Arabia Digital Therapeutics Market Size: Forecast (2026- 2032)

The Saudi Arabia Digital Therapeutics Market size is valued at around USD 34 million in 2025 and is projected to reach USD 62 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 8.96% during the forecast period, i.e., 2026-32.

The Saudi Arabia Digital Therapeutics Market is expanding rapidly, driven by rising chronic disease prevalence and rapid digital-health modernization. National health statistics show that nearly one-quarter of adults are obese, while 45.1% are overweight, creating a sizable population requiring continuous metabolic, behavioral, and medication support.

This burden is compounded by complex comorbidities, as a 2023 retrospective study found that among individuals with type 2 diabetes, 67.7% also had hypertension, 69.0% had dyslipidemia, 18.6% were living with ASCVD, 8.7% had chronic kidney disease, and 5.1% had heart failure. These patterns highlight an urgent need for scalable, software-enabled disease-management solutions.

AI-powered personalized health coaching is becoming central to that response. Platforms such as Sehhaty increasingly integrate predictive-risk tools and AI-guided lifestyle pathways, enabling more precise preventive care. At the same time, hospitals and insurers are accelerating the shift toward home-based rehabilitation and continuous remote monitoring, supporting digital physiotherapy, cardiac rehabilitation, and mental-wellness programs. This migration toward virtual, AI-enabled care underscores the Kingdom’s broader move toward digital therapeutics as a standard of care.

The National Health Intelligence Initiative (NHI), launched in late 2025, is designed to unify Saudi Arabia’s health datasets and deploy population-scale predictive analytics as an essential foundation for advanced DTx models. Meanwhile, Seha Virtual Hospital continues expanding its network, improving access to AI-supported diagnostics and remote chronic-disease management, particularly in underserved regions.

Long-term investment reinforces this trajectory. The Ministry of Health has allocated over USD 33 billion to healthcare transformation, including AI integration, telemedicine infrastructure, and nationwide EHR interoperability. These developments will deepen preventive care, streamline chronic-disease management, and embed DTx solutions across clinical pathways, positioning digital therapeutics as a core pillar of Saudi Arabia’s future healthcare system.

Overall, the convergence of chronic-disease burdens, nationwide AI integration, expanding virtual-care infrastructure, and future health investments ensures strong forward momentum, positioning digital therapeutics for sustained, accelerated growth across Saudi Arabia’s healthcare ecosystem in the coming years.

Saudi Arabia Digital Therapeutics Market Recent Developments:

• February 2025: Aster DM Healthcare launched its myAster digital-health app in Saudi Arabia, introducing teleconsultations, e-pharmacy services, chronic-care tools, and AI-driven Arabic voice assistance developed with Google Cloud. The rollout marks a major step in Aster’s USD 250 million plan to expand integrated digital and physical healthcare services across the Kingdom.
• October 2025: Saudi Arabia’s Ministry of Health designated Sehhaty as the unified national e-health platform and, in collaboration with Lean Business Services and Google Cloud, introduced an AI-driven Smart Health Coach. The new feature delivers personalized guidance, health monitoring, and preventive-care support, strengthening the Kingdom’s digital-therapeutics ecosystem.

Saudi Arabia Digital Therapeutics Market Scope:

Saudi Arabia Digital Therapeutics Market Drivers:

High Prevalence of Chronic Disease

The high prevalence of chronic diseases in Saudi Arabia, particularly obesity, diabetes, and cardiovascular diseases, continues to accelerate demand for digital therapeutics that enable ongoing monitoring, early intervention, and scalable long-term disease management. A national evidence review shows obesity rates ranging from 20–39%, with 60.7% of obese adults living with type 2 diabetes and 67.6% with hypertension, underscoring the scale of multi-morbidity and the need for continuous, technology-enabled care.

Cardiovascular disease (CVD) trends further underscore the urgency for scalable digital health solutions. A 2024 population-based analysis reports that 1.6% of adults currently live with CVD. Still, prevalence escalates to 11% among individuals aged 65 and above, highlighting the rising burden of long-term disease management as the population ages.

Alongside health implications, chronic diseases pose an immense economic challenge as obesity and its related illnesses generate an estimated USD 116.85 billion in annual economic losses, with USD 109.7 billion directly absorbed by the healthcare system, placing sustained pressure on national resources.

Beyond 2025, national strategies targeting obesity reduction, preventive care, and digital health integration are expected to expand, supporting digital therapeutics for lifestyle modification, remote monitoring, and metabolic-risk management. As chronic-disease rates rise, DTx adoption will accelerate, offering scalable, cost-effective care for a growing high-risk population.

Overall, the growing chronic-disease burden, rising healthcare costs, and government-backed digital-health expansion will significantly strengthen the long-term demand for digital therapeutics across Saudi Arabia.

Saudi Arabia Digital Therapeutics Market Trends:

Expansion of AI-Powered Personalized Health Coaching

The rapid expansion of AI-powered personalized health coaching is accelerating digital-therapeutics uptake in Saudi Arabia. For instance, Seha Virtual Hospital (SVH), the Kingdom’s flagship virtual-care ecosystem, has significantly expanded over the past two years. By mid-2025, it was integrated with more than 200 hospitals across the country, enabling AI-supported diagnostics, remote clinical evaluations, and specialist consultations, broadening access to personalized, data-driven healthcare services nationwide.

A significant milestone in Saudi Arabia’s digital-health evolution is the rollout of iSelfie.ai in the Makkah Health Cluster in June 2025. This AI solution uses a brief facial video to estimate key vital signs including blood pressure, heart rate, respiratory rate, and oxygen saturation without requiring any medical hardware. Its deployment supports continuous, accessible monitoring for patients managing chronic conditions or undergoing preventive screening.

Confidence in AI-enabled care is also strengthening across the healthcare system. A national survey conducted in 2023 found that 96% of Saudi healthcare leaders expect to increase their investments in AI within the next three years, demonstrating strong institutional momentum toward intelligent coaching, remote diagnostics, and automated patient-management tools.

Together, advanced AI technologies, committed leadership, and expanding national data platforms are transforming personalized care. This coordinated progress is expected to significantly boost the adoption of digital therapeutics across the Kingdom.

Saudi Arabia Digital Therapeutics Market Challenges:

Limited Clinical Validation and Physician Acceptance

Limited clinical validation and moderate physician acceptance remain key constraints for Saudi Arabia’s digital-therapeutics expansion. A 2025 qualitative study involving physicians in the Kingdom highlighted persistent concerns regarding system usability, performance reliability, and insufficient supporting infrastructure, all of which reduced clinicians’ willingness to integrate mobile-health tools into routine practice.

A separate 2025 assessment conducted during the Hajj season further underscored this hesitation, revealing that only 39.4% of healthcare workers strongly endorsed the clinical usefulness of digital platforms, while 35.5% felt these tools had meaningfully improved their daily workflows. Such findings signal that digital therapeutics are not yet perceived as essential clinical instruments.

Additional challenges were reported in a 2025 Riyadh-based evaluation of EHR-linked telehealth systems, which found that workflow disruptions, limited reimbursement pathways, and uncertainty over platform suitability for complex cases continue to restrict adoption.

Collectively, these issues limited validation, workflow misalignment, and low clinician confidence, posing significant obstacles to scaling digital therapeutics. Without stronger evidence and better integration with clinical processes, market growth will remain constrained.

Saudi Arabia Digital Therapeutics Market (2026-32) Segmentation Analysis:

The Saudi Arabia Digital Therapeutics Market Report and Forecast 2026-2032 offers a detailed analysis of the market based on the following segments:

Based on Type of Solution

• Software Solution
• Gaming Solution
• Combination Solution

The software solution segment holds the top spot in the Saudi Arabia Digital Therapeutics Market, driven by strong adoption across chronic-disease management, mental-wellness programs, remote monitoring, and AI-based preventive-care platforms.

Software-based DTx integrates seamlessly with national digital-health systems such as the Sehhaty app, the Seha Virtual Hospital network, and expanding EHR interoperability initiatives, making it the most scalable and clinically adaptable segment.

Hospitals and insurers increasingly rely on software-driven interventions for diabetes management, cardiovascular monitoring, lifestyle-modification guidance, and medication adherence, areas where structured, evidence-based modules outperform gaming interfaces in clinical consistency and regulatory compliance.

Moreover, government-backed investments in AI, virtual care, and population-health analytics further accelerate software deployment, as these systems can rapidly update clinical pathways, integrate real-world data, and support multilingual, nationwide rollouts.

Overall, software solutions dominate due to their broader clinical acceptance, integration capability, and alignment with Saudi Arabia’s long-term digital-health transformation agenda.

Based on End User

• Healthcare Providers
• Insurance Companies
• Individuals
• Employers
• Others

The healthcare providers lead the Saudi Arabia Digital Therapeutics Industry, driven by rapid digital-health transformation across hospitals and primary care networks. The Ministry of Health’s nationwide rollout of telemedicine, AI-assisted decision-support tools, and virtual chronic-disease programs has positioned providers at the center of DTx deployment.

Seha Virtual Hospital, for example, now supports remote monitoring, digital rehabilitation, and AI-enabled consultations across all regions, creating strong clinical demand for integrated therapeutic software.

Hospitals increasingly use DTx solutions for diabetes management, cardiac rehabilitation, obesity interventions, mental-health support, and post-operative recovery, aligning with the Kingdom’s push toward value-based and preventive care.

Clinical providers also benefit from unified EHR ecosystems and expanding Health Information Exchange (HIE) infrastructure, which make DTx integration more seamless than for insurers or employers.

Individuals, insurers, and employers are growing users, but the clinical reliance, regulatory alignment, and workflow integration achieved by healthcare providers keep this segment at the forefront of DTx adoption.

Leading Players of the Saudi Arabia Digital Therapeutics Market:

• Cura

Cura was founded in 2016 and headquartered in Riyadh, Saudi Arabia, is recognized as one of the Kingdom’s leading digital-health innovators. The platform specializes in virtual clinical consultations, digital behavioral-health programs, and chronic-disease support delivered through app-based care pathways. Cura’s expertise lies in enabling remote access to certified physicians and psychologists, integrating personalized treatment plans, and expanding digital-therapeutic models aligned with Saudi Arabia’s national telehealth and preventive-care objectives.

• Alma Health

Alma Health was established in 2021, is headquartered in Abu Dhabi, UAE, and operates across Saudi Arabia. The company focuses on end-to-end digital care for chronic-disease patients, offering app-based consultations, medication management, home delivery of prescriptions, and continuous condition monitoring.

• Omada Health

Omada Health was founded in 2011 and is based in San Francisco, United States. It is a global pioneer in digital therapeutics, specializing in clinically validated programs for diabetes prevention, diabetes management, hypertension, musculoskeletal conditions, and behavioral health. Its expertise lies in delivering measurable health-outcome improvements at scale, positioning Omada as a reference model for emerging DTx ecosystems worldwide.

Alphaiota, Clinicy, Twill Health, and others are the key players of the Saudi Arabia Digital Therapeutics Market.

Saudi Arabia Digital Therapeutics Market (2026-32): Regional Projection

The Saudi Arabia Digital Therapeutics Market is dominated by the Riyadh region, supported by its status as the country’s primary healthcare, regulatory, and digital-innovation hub. The region hosts the Kingdom’s largest concentration of tertiary hospitals, research centers, and digital-health programs, including Seha Virtual Hospital, which operates from Riyadh and anchors nationwide telemedicine and AI-enabled care. The Ministry of Health, Saudi Health Council, and major digital-health regulators are also headquartered in the city, enabling faster piloting, approval, and deployment of DTx solutions.

In April 2025, the Riyadh region inaugurated 28 health projects across public, private, and nonprofit sectors, worth more than USD 1.87 billion, including expanded hospital capacity and specialty centers, strengthening the infrastructure to support digital therapeutics.

Riyadh’s population density and high chronic-disease burden, particularly obesity and diabetes, drive strong demand for scalable digital-therapeutic tools. The region has also achieved the highest adoption of national health apps such as Sehhaty and Tawakkalna, supported by advanced ICT infrastructure and strong private-sector investment in AI, cloud health platforms, and remote-monitoring technologies. This ecosystem makes Riyadh the most mature and innovation-ready environment, positioning it as the leading region for digital-therapeutic expansion.

Gain a Competitive Edge with Our Saudi Arabia Digital Therapeutics Market Report 

• Saudi Arabia Digital Therapeutics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions. 
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition. 
• Saudi Arabia Digital Therapeutics Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.